Xcout Intel
TargED Biopharmaceuticals competitors & alternatives
The 12 closest competitors and alternatives to TargED Biopharmaceuticals among biotechnology companies — ranked by similarity to what TargED Biopharmaceuticals actually does, not by market-cap band.
Subscribe to see TargED Biopharmaceuticals’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About TargED Biopharmaceuticals
TargED Biopharmaceuticals is a Netherlands-based biotechnology company that develops first-class biological drugs to improve the treatment of thrombosis. The company utilizes small antibodies to deliver enzymes directly to blood clots, aiming to provide targeted thrombolysis for patients suffering from various thrombotic disorders.
TargED Biopharmaceuticals at a glance
TargED Biopharmaceuticals is a biotechnology company headquartered in Netherlands. Xcout tracks 4 named people at TargED Biopharmaceuticals, including Coen Maas (Co-founder).
TargED Biopharmaceuticals leadership
- Coen MaasCo-founder
- Kristof VercruysseCo-founder
- Marc van MoorselCo-founder
- Steven de MaatCo-founder
Top 12 TargED Biopharmaceuticals competitors
Ranked by semantic similarity — how close each company is to TargED Biopharmaceuticals by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
BioTech
Acticor Biotech is a clinical-stage biopharmaceutical company headquartered in Paris, France, that specializes in developing innovative treatments for acute thrombotic diseases.
BioTech
River BioMedics is a Dutch biotechnology company headquartered in Enschede, Netherlands, founded in 2018. The company focuses on cardiovascular drug discovery by utilizing proprietary 3D human engineered heart tissue models to address unmet medical needs.
Similar biotechnology company
Vaderis Therapeutics AG is a clinical-stage biotechnology company focused on developing novel treatments for severe vascular diseases. The company is headquartered in Basel, Switzerland.
Similar biotechnology company
Repair Biotechnologies develops a proprietary Cholesterol Degrading Platform to treat medical conditions caused by localized cholesterol accumulations. Its primary focus is creating therapies that rapidly reduce atherosclerotic plaque in arteries to combat cardiovascular disease.
Biotech
AAVantgarde Bio is an Italian biotechnology company developing adeno-associated virus (AAV) gene therapies for rare genetic diseases, including conditions caused by genes too large to fit into a single AAV vector. Its technology uses dual-AAV approaches to deliver larger therapeutic genes, serving patients with serious inherited disorders and the clinicians who treat them.
Similar biotechnology company
Phlox Therapeutics is a private biotechnology company pioneering RNA-based gene therapies to alleviate and cure severe genetic heart diseases and cardiomyopathies. Headquartered in Naarden, Netherlands, the company focuses on innovative cardiovascular treatments.
Biotech
Philogen is a Swiss-Italian biotechnology company that focuses on the research, development, and commercialization of targeted therapeutics for the treatment of cancer and other serious conditions. The company utilizes proprietary antibody-based technologies to develop biopharmaceuticals, immunotherapies, and radio-conjugates for oncology and imaging applications.
Similar biotechnology company
InteRNA Technologies is a venture-backed biotech and life sciences company founded in 2008 and headquartered in Utrecht, Netherlands. The company specializes in the development of microRNA (miRNA)-focused drug pipelines and therapeutics. It operates within the biopharmaceutical sector, supported by various institutional backers and investors.
Similar biotechnology company
Bioxodes is a Belgian clinical-stage biotechnology company founded in 2013 and located in Gosselies. The firm focuses on developing breakthrough treatments for hemorrhagic stroke patients.
Similar biotechnology company
Plantibodies is a biotechnology company headquartered in Paris, France, specializing in the development of plant-based oral immunotherapies. Designed to act locally in the body, the company's biological innovations aim to revolutionize biologics and healthcare. Plantibodies has raised funding from leading business angel networks to support its early-stage research.
Biotech
Oxurion N.V. is a biopharmaceutical enterprise dedicated to the research, development, and marketing of innovative treatments for ocular diseases, operating both within Belgium and across international markets. Its primary commercialized therapy is JETREA, prescribed for vitreomacular adhesion and vitreomacular traction. Beyond this, Oxurion's clinical pipeline includes two promising compounds in Phase II trials for diabetic macular edema (DME): THR-149, which functions as a plasma kallikrein inhibitor, and THR-687, an integrin antagonist. The company also fosters collaborative relationships with Bicycle Therapeutics, INC Research, and Galapagos NV. Founded in 1991, this Leuven, Belgium-headquartered firm adopted its current name, Oxurion N.V., in September 2018, having previously operated as ThromboGenics NV.
Diagnostics
ABSCINT is a clinical-stage biotechnology company that develops platform production processes for rapid creation of cold kits for molecular imaging in oncology and immunology. Headquartered in Belgium, the privately held firm focuses on innovative diagnostic and therapeutic applications using single-domain antibodies.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of TargED Biopharmaceuticals and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for TargED Biopharmaceuticalsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →